Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAB33B antisense RNA 1 (RAB33B-AS1) is a long non-coding RNA (lncRNA) gene. It is classified as an antisense RNA because its transcript is complementary to the RAB33B gene (located on the opposite strand), but it does not encode a protein[6][7][9]. Like other natural antisense transcripts, RAB33B-AS1 may regulate RAB33B gene expression through various mechanisms, such as transcriptional interference, RNA duplex formation, or influencing RNA stability, though its specific functions are currently not well characterized in public gene function resources[6][7][9]. There is no information identifying RAB33B-AS1 as a therapeutic drug target, no known drug interactions, biomarker utility, or notable safety/therapeutic challenges. Its roles in physiological or disease processes have not been firmly established in the literature cited by major genomic databases[6][7][9]. \n\n**Note:** \n- RAB33B-AS1 should not be confused with RAB33B, a small GTPase involved in membrane trafficking and autophagy, which is sometimes associated with diseases—but RAB33B-AS1 is a distinct non-protein-coding transcript[6][7][9]. \n- No evidence supports its role as a receptor, enzyme, or other common therapeutic target molecule class. \n- Its biological and clinical significance remains to be clarified in ongoing research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAB33B antisense RNA 1 (RAB33B-AS1).